Sakamakon gwajin mataki na 2 ya goyi bayan ra'ayin cewa allurar IFN-β ta ƙarƙashin ƙasa don maganin COVID-19 tana ƙara saurin murmurewa kuma tana rage mace-mace.
Wannan yanayi na musamman da annobar COVID-19 ta gabatar ya bukaci a binciko hanyoyi daban-daban na magance matsalolin COVID-19 masu tsanani. Ana gwada sabbin magunguna da dama kuma ana sake amfani da magungunan da ake da su. An riga an gano cewa magungunan Corticosteroids suna da amfani. An riga an fara amfani da maganin Interferon don kamuwa da cututtukan ƙwayoyin cuta kamar hepatitis. Shin za a iya amfani da IFN don magance SARS CoV-2 a COVID-19?
A gwaje-gwajen da aka yi kafin a fara gwaji a baya, IFN ta tabbatar da cewa tana da tasiri a kan ƙwayoyin cuta na SARS CoV da MERS . A watan Yulin 2020, an ruwaito cewa shan Interferon-β ta hanyar amfani da nebulization (misali, shaƙar huhu) ya nuna sakamako mai kyau wajen magance matsalolin COVID-19 masu tsanani bisa ga bayanai daga gwajin asibiti na mataki na 2 1,2.
Yanzu, sabon rahoto da aka bayar dangane da bayanai daga gwajin asibiti na mataki na 2 da aka gudanar kan marasa lafiya 112 da ke dauke da COVID-19 da aka kwantar a asibiti a Pitié-Salpêtrière da ke Paris, Faransa ya nuna cewa allurar IFN-β ta hanyar hanyar karkashin kasa tana kara saurin murmurewa kuma tana rage mace-mace a cikin wadanda suka kamu da cutar COVID-19 3.
Interferons (IFN) sunadarai ne da ƙwayoyin cuta ke fitarwa don mayar da martani ga kamuwa da ƙwayoyin cuta don nuna wa sauran ƙwayoyin cuta cewa akwai ƙwayar cuta. An gano cewa amsawar kumburi mai yawa a wasu daga cikin marasa lafiya na COVID-19 yana da alaƙa da raunin amsawar IFN-1 da toshe fitar IFN-β . Ana amfani da shi a China don magance ciwon huhu na ƙwayoyin cuta saboda SARS CoV amma amfani da shi ba a daidaita shi ba 4.
Gwajin gwaji na asibiti na kashi 3 don amfani da Interferon (IFN) don kula da masu cutar COVID-19 mai tsanani a halin yanzu yana kan ci gaba. Amincewa zai dogara ne akan ko sakamakon ƙarshe yana cikin kewayon karɓuwa wanda masu gudanarwa suka tsara.
***
Sources:
- NHS 2020. Labarai- Magungunan da aka shaka yana hana marasa lafiya COVID-19 yin muni a gwajin Southampton. An buga akan 20 Yuli 2020. Akwai akan layi a https://www.uhs.nhs.uk/ClinicalResearchinSouthampton/Research/News-and-updates/Articles/Inhaled-drug-prevents-COVID-19-patients-getting-worse-in-Southampton-trial.aspx An shiga ranar 12 ga Fabrairu, 2021.
- Monk PD., Marsden RJ., Tear VJ., et al., 2020. Tsaro da ingancin inhaled interferon beta-1a (SNG001) don lura da SARS-CoV-2 kamuwa da cuta: bazuwar, biyu-makafi, placebo- sarrafawa, gwaji na lokaci 2. Magungunan Numfashi na Lancet, Akwai akan layi 12 Nuwamba 2020. DOI: https://doi.org/10.1016/S2213-2600(20)30511-7
- Dorgham K., Neumann AU., et al 2021. Yin la'akari da keɓaɓɓen maganin Interferon-β don COVID-19. Magungunan rigakafi Chemotherapy. An buga Online 8 Fabrairu 2021. DOI: https://doi.org/10.1128/AAC.00065-21
- Mary A., Hénaut L., Macq PY., et al 2020. Dalilin COVID-19 Jiyya ta Nebulized Interferon-β-1b-Bita na Adabi da Ƙwarewar Farko na Keɓaɓɓu. Ƙididdiga a Ilimin Magunguna., 30 Nuwamba 2020. DOI:https://doi.org/10.3389/fphar.2020.592543.
***
